Journey Medical Corp Stock Performance
| DERM Stock | USD 8.45 0.12 1.44% |
Journey Medical has a performance score of 1 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.32, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Journey Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Journey Medical is expected to be smaller as well. Journey Medical Corp right now retains a risk of 3.77%. Please check out Journey Medical value at risk, as well as the relationship between the skewness and day median price , to decide if Journey Medical will be following its current trending patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Journey Medical Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Journey Medical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return 1.44 | Five Day Return (8.25) | Year To Date Return 13.42 | Ten Year Return (11.05) | All Time Return (11.05) |
1 | Journey Medical Corporation Reports Q3 Loss, Lags Revenue Estimates | 11/12/2025 |
2 | Journey Medical Corporation Q3 2025 Earnings Call Transcript | 11/14/2025 |
3 | Journey Medical Corp Q3 2025 Earnings Call Highlights Strong Revenue Growth and ... | 11/18/2025 |
4 | Envestnet Asset Management Inc. Decreases Holdings in Journey Medical Corporation DERM - MarketBeat | 11/25/2025 |
5 | Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi on Microbial Flora of Healthy Adults in the Journal o... | 12/10/2025 |
6 | Behavioral Patterns of DERM and Institutional Flows - Stock Traders Daily | 12/26/2025 |
7 | and the Role of Price-Sensitive Allocations - Stock Traders Daily | 01/06/2026 |
8 | Journey Medical Publishes Positive Emrosi Phase 1 Microbiome Data | 01/08/2026 |
9 | Journey Medical Corporation Given Average Recommendation of Hold by Analysts - MarketBeat | 01/16/2026 |
10 | Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock - TradingView | 01/23/2026 |
| Begin Period Cash Flow | 27.4 M | |
| Total Cashflows From Investing Activities | -15 M |
Journey Medical Relative Risk vs. Return Landscape
If you would invest 852.00 in Journey Medical Corp on November 1, 2025 and sell it today you would lose (7.00) from holding Journey Medical Corp or give up 0.82% of portfolio value over 90 days. Journey Medical Corp is currently generating 0.058% in daily expected returns and assumes 3.7708% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Journey, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Journey Medical Target Price Odds to finish over Current Price
The tendency of Journey Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.45 | 90 days | 8.45 | about 21.96 |
Based on a normal probability distribution, the odds of Journey Medical to move above the current price in 90 days from now is about 21.96 (This Journey Medical Corp probability density function shows the probability of Journey Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Journey Medical has a beta of 0.32 suggesting as returns on the market go up, Journey Medical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Journey Medical Corp will be expected to be much smaller as well. Additionally Journey Medical Corp has an alpha of 0.236, implying that it can generate a 0.24 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Journey Medical Price Density |
| Price |
Predictive Modules for Journey Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Journey Medical Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Journey Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Journey Medical is not an exception. The market had few large corrections towards the Journey Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Journey Medical Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Journey Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.24 | |
β | Beta against Dow Jones | 0.32 | |
σ | Overall volatility | 0.53 | |
Ir | Information ratio | 0.05 |
Journey Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Journey Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Journey Medical Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Journey Medical Corp had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 56.13 M. Net Loss for the year was (14.67 M) with profit before overhead, payroll, taxes, and interest of 39.23 M. | |
| Journey Medical Corp currently holds about 38.14 M in cash with (9.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.17. | |
| Roughly 24.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock - TradingView |
Journey Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Journey Stock often depends not only on the future outlook of the current and potential Journey Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Journey Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.4 M | |
| Cash And Short Term Investments | 20.3 M |
Journey Medical Fundamentals Growth
Journey Stock prices reflect investors' perceptions of the future prospects and financial health of Journey Medical, and Journey Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Journey Stock performance.
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.046 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 278.38 M | ||||
| Shares Outstanding | 27.26 M | ||||
| Price To Earning | (9.50) X | ||||
| Price To Book | 10.74 X | ||||
| Price To Sales | 4.66 X | ||||
| Revenue | 56.13 M | ||||
| Gross Profit | 39.23 M | ||||
| EBITDA | (8.4 M) | ||||
| Net Income | (14.67 M) | ||||
| Cash And Equivalents | 38.14 M | ||||
| Cash Per Share | 2.17 X | ||||
| Total Debt | 25.7 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 1.40 X | ||||
| Book Value Per Share | 0.98 X | ||||
| Cash Flow From Operations | (9.13 M) | ||||
| Earnings Per Share | (0.35) X | ||||
| Market Capitalization | 277.03 M | ||||
| Total Asset | 80.24 M | ||||
| Retained Earnings | (87.03 M) | ||||
| Working Capital | 13 M | ||||
| Current Asset | 217.23 M | ||||
| Current Liabilities | 25.9 M | ||||
About Journey Medical Performance
By examining Journey Medical's fundamental ratios, stakeholders can obtain critical insights into Journey Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Journey Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 290.12 | 524.04 | |
| Return On Tangible Assets | (0.27) | (0.29) | |
| Return On Capital Employed | (0.27) | (0.29) | |
| Return On Assets | (0.16) | (0.17) | |
| Return On Equity | (0.84) | (0.80) |
Things to note about Journey Medical Corp performance evaluation
Checking the ongoing alerts about Journey Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Journey Medical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Journey Medical Corp had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 56.13 M. Net Loss for the year was (14.67 M) with profit before overhead, payroll, taxes, and interest of 39.23 M. | |
| Journey Medical Corp currently holds about 38.14 M in cash with (9.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.17. | |
| Roughly 24.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock - TradingView |
- Analyzing Journey Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Journey Medical's stock is overvalued or undervalued compared to its peers.
- Examining Journey Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Journey Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Journey Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Journey Medical's stock. These opinions can provide insight into Journey Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value—what Journey Medical's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.